With many manufacturers experimenting with outcomes-based pricing, Jeremy Schafer, senior vice president, director, Payer Access Solutions, offers his expertise on whether this approach should become standard for all specialty drug launches. (more…)

Dan Renick is a featured expert on drug pricing and defining value as a source for the Med Ad News Special Feature, “The Value Equation.” (more…)

Precision for Value’s Jeremy Schafer is featured in Managed Healthcare Executive, offering expert insight on how rebates contribute to patient savings as well as greater transparency among stakeholders. (more…)

Andrew Cournoyer, vice president at Precision for Value, offers an initial reaction to CMS’s new flexibility on offering benefits and controlling costs, which are expected to grow the Medicare Advantage program. (more…)